Logo of Robert Koch InstituteLogo of Robert Koch Institute
Publication Server of Robert Koch Instituteedoc
de|en
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
2013-05-27Zeitschriftenartikel DOI: 10.1007/s00103-012-1659-0
Prevalence of stroke in adults aged 40–79 years in Germany
Results of the German Health Interview and Examination Survey for Adults (DEGS1)
Busch, Markus
Schienkiewitz, Anja
Nowossadeck, Enno
Gößwald, Antje
In the German Health Interview and Examination Survey (DEGS1), data on the prevalence of physician-diagnosed stroke were collected from 2008 to 2011 in a representative population-based sample of 5,901 adults aged 40–79 years. The stroke prevalence in DEGS1 was compared with prevalence estimates from the German National Health Interview and Examination Survey 1998 (GNHIES98). The lifetime prevalence of stroke in adults aged 40–79 years is 2.9% (women: 2.5%; men: 3.3%). In both sexes, the prevalence increases continuously with age, up to 6.3% in women and 8.1% in men 70–79 years old. More pronounced in women than in men, the prevalence of stroke decreases with increasing socioeconomic status. Compared to GNHIES98, there is no evidence for a change in stroke prevalence over time. The prevalence of stroke in adults aged 40–79 years in Germany is comparable to prevalence estimates from other national and international studies. Further studies should examine the reasons behind stable prevalence rates, accounting for population ageing and changes in incidence, mortality and case fatality rates.
Files in this item
Thumbnail
27Sbld1R4s96.pdf — Adobe PDF — 316.5 Kb
MD5: 1db3bcc2de22b52386fe5264d56d79ac
Cite
BibTeX
EndNote
RIS
No license information
Details
Terms of Use Imprint Policy Data Privacy Statement Contact

The Robert Koch Institute is a Federal Institute

within the portfolio of the Federal Ministry of Health

© Robert Koch Institute

All rights reserved unless explicitly granted.

 
DOI
10.1007/s00103-012-1659-0
Permanent URL
https://doi.org/10.1007/s00103-012-1659-0
HTML
<a href="https://doi.org/10.1007/s00103-012-1659-0">https://doi.org/10.1007/s00103-012-1659-0</a>